Michael Celano Insider Trading
Get free email notifications about insider trading for Michael Celano.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Celano. Michael Celano is a Director in ORASURE TECHNOLOGIES INC ($OSUR) and a Chief Financial Officer in Larimar Therapeutics, Inc. ($ZFGN) and a Chief Financial Officer in Recro Pharma, Inc. ($REPH) and a Chief Operating Officer in Recro Pharma, Inc. ($REPH).
Address: 220 EAST FIRST STREET BETHLEHEM 18015 PA
Companies in which Michael Celano is an Insider
Larimar Therapeutics, Inc.
Trading Symbol: LRMRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Celano: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 21 2021
$LRMR Market Capitalization: $109.05M
$LRMR Previous Close: $4.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ORASURE TECHNOLOGIES INC
Trading Symbol: OSURIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Michael Celano: Director
Holdings: 58,799 shares
Current Value: $518,607
Latest Transaction: May 19 2020
$OSUR Market Capitalization: $493.21M
$OSUR Previous Close: $8.82
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Recro Pharma, Inc.
Trading Symbol: REPHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Celano: Chief Operating Officer, Chief Financial Officer
Holdings: 39,445 shares
Current Value: $317,532
Latest Transaction: Jan 23 2019
$REPH Market Capitalization: $98.40M
$REPH Previous Close: $8.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Michael Celano
Sentiment: All, LRMR, OSUR, REPH
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 21 2021 | ZFGN | Larimar Therapeuti ... | Celano Michael | Chief Financial Off ... | Option Exercise | A | 19.61 | 42,000 | 823,620 | 42,000 | |
Sep 30 2020 | ZFGN | Larimar Therapeuti ... | Celano Michael | Chief Financial Off ... | Option Exercise | A | 11.90 | 84,100 | 1,000,790 | 84,100 | |
Jun 05 2020 | ZFGN | Larimar Therapeuti ... | Celano Michael | Chief Financial Off ... | Option Exercise | A | 11.88 | 60,479 | 718,491 | 60,479 | |
May 19 2020 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Grant | A | 15.97 | 8,143 | 130,003 | 66,942 | 58.8 K to 66.9 K (+13.85 %) |
May 19 2020 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Payment of Exercise | F | 16.04 | 3,843 | 61,642 | 58,799 | 62.6 K to 58.8 K (-6.13 %) |
May 19 2020 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Grant | A | 15.97 | 8,143 | 130,003 | 66,942 | 58.8 K to 66.9 K (+13.85 %) |
May 19 2020 | OSUR | ORASURE TECHNOLOGI ... | Celano Michael | Director | Payment of Exercise | F | 16.04 | 3,843 | 61,642 | 58,799 | 62.6 K to 58.8 K (-6.13 %) |